In Vivo Animal Stroke Models: A Rationale for Rodent and Non-Human Primate Models

Naoki Tajiri, Travis Dailey, Christopher Metcalf, Yusef I. Mosley, Tsz Lau, Meaghan Staples, Harry van Loveren, Seung U. Kim, Tetsumori Yamashima, Takao Yasuhara, Isao Date, Yuji Kaneko, Cesario V. Borlongan

Research output: Contribution to journalReview articlepeer-review

44 Citations (Scopus)


On average, every 4 min an individual dies from a stroke, accounting for one out of every 18 deaths in the United States. Approximately 795,000 Americans have a new or recurrent stroke each year, with just over 600,000 of these being first attack Roger et al. (Circulation, 125(1): 188-197, 2012). There have been multiple animal models of stroke demonstrating that novel therapeutics can help improve the clinical outcome. However, these results have failed to show the same outcomes when tested in human clinical trials. This review will discuss the current in vivo animal models of stroke, advantages and limitations, and the rationale for employing these animal models to satisfy translational gating items for examination of neuroprotective, as well as neurorestorative strategies in stroke patients. An emphasis in the present discussion of therapeutics development is given to stem cell therapy for stroke.

Original languageEnglish
Pages (from-to)308-321
Number of pages14
JournalTranslational Stroke Research
Issue number3
Publication statusPublished - Jun 2013


  • Animals
  • Basic research
  • Cerebral ischemia
  • Clinical application
  • Translational

ASJC Scopus subject areas

  • General Neuroscience
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'In Vivo Animal Stroke Models: A Rationale for Rodent and Non-Human Primate Models'. Together they form a unique fingerprint.

Cite this